🎉 M&A multiples are live!
Check it out!

Legend Biotech Valuation Multiples

Discover revenue and EBITDA valuation multiples for Legend Biotech and similar public comparables like Pharming, Vivoryon Therapeutics, and Galapagos.

Legend Biotech Overview

About Legend Biotech

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.


Founded

2015

HQ

United States of America
Employees

2.6K+

Financials

LTM Revenue $742M

LTM EBITDA -$179M

EV

$5.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Legend Biotech Financials

Legend Biotech has a last 12-month revenue of $742M and a last 12-month EBITDA of -$179M.

In the most recent fiscal year, Legend Biotech achieved revenue of $627M and an EBITDA of -$113M.

Legend Biotech expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Legend Biotech valuation multiples based on analyst estimates

Legend Biotech P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $285M $627M XXX XXX XXX
Gross Profit $51.6M $141M XXX XXX XXX
Gross Margin 18% 22% XXX XXX XXX
EBITDA -$478M -$113M XXX XXX XXX
EBITDA Margin -168% -18% XXX XXX XXX
Net Profit -$446M -$518M XXX XXX XXX
Net Margin -157% -83% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Legend Biotech Stock Performance

As of April 15, 2025, Legend Biotech's stock price is $32.

Legend Biotech has current market cap of $5.9B, and EV of $5.1B.

See Legend Biotech trading valuation data

Legend Biotech Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$5.1B $5.9B XXX XXX XXX XXX $-0.45

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Legend Biotech Valuation Multiples

As of April 15, 2025, Legend Biotech has market cap of $5.9B and EV of $5.1B.

Legend Biotech's trades at 6.9x LTM EV/Revenue multiple, and -28.7x LTM EBITDA.

Analysts estimate Legend Biotech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Legend Biotech and 10K+ public comps

Legend Biotech Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $5.1B XXX XXX XXX
EV/Revenue 8.2x XXX XXX XXX
EV/EBITDA -45.3x XXX XXX XXX
P/E -33.3x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -32.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Legend Biotech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Legend Biotech Valuation Multiples

Legend Biotech's NTM/LTM revenue growth is 59%

Legend Biotech's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, Legend Biotech's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Legend Biotech's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Legend Biotech and other 10K+ public comps

Legend Biotech Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 120% XXX XXX XXX XXX
EBITDA Margin -18% XXX XXX XXX XXX
EBITDA Growth -76% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 41% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue 24% XXX XXX XXX XXX
G&A Expenses to Revenue 22% XXX XXX XXX XXX
R&D Expenses to Revenue 66% XXX XXX XXX XXX
Opex to Revenue 111% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Legend Biotech Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Legend Biotech M&A and Investment Activity

Legend Biotech acquired  XXX companies to date.

Last acquisition by Legend Biotech was  XXXXXXXX, XXXXX XXXXX XXXXXX . Legend Biotech acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Legend Biotech

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Legend Biotech

When was Legend Biotech founded? Legend Biotech was founded in 2015.
Where is Legend Biotech headquartered? Legend Biotech is headquartered in United States of America.
How many employees does Legend Biotech have? As of today, Legend Biotech has 2.6K+ employees.
Who is the CEO of Legend Biotech? Legend Biotech's CEO is Dr. Ying Huang, PhD.
Is Legend Biotech publicy listed? Yes, Legend Biotech is a public company listed on NAS.
What is the stock symbol of Legend Biotech? Legend Biotech trades under LEGN ticker.
When did Legend Biotech go public? Legend Biotech went public in 2020.
Who are competitors of Legend Biotech? Similar companies to Legend Biotech include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Legend Biotech? Legend Biotech's current market cap is $5.9B
What is the current revenue of Legend Biotech? Legend Biotech's last 12-month revenue is $742M.
What is the current EBITDA of Legend Biotech? Legend Biotech's last 12-month EBITDA is -$179M.
What is the current EV/Revenue multiple of Legend Biotech? Current revenue multiple of Legend Biotech is 6.9x.
What is the current EV/EBITDA multiple of Legend Biotech? Current EBITDA multiple of Legend Biotech is -28.7x.
What is the current revenue growth of Legend Biotech? Legend Biotech revenue growth between 2023 and 2024 was 120%.
Is Legend Biotech profitable? Yes, Legend Biotech is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.